Athanase Innovation AB (FRA:H6H) Research & Development: €0.00 Mil (TTM As of Dec. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6H Athanase Innovation AB FRA:H6H
26 GF Score
Price €1.77
View Full Analysis

What is Athanase Innovation AB Research & Development?

Athanase Innovation AB FRA:H6H -1.12% 26 Research & Development is €0.00 Mil as of Dec. 2020. GuruFocus rates FRA:H6H with a GF Score™ of 26/100.

Research & Development is the aggregate amount of research and development expenses during the year. Athanase Innovation AB's Research & Development for the six months ended in Dec. 2020 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2020 was €0.00 Mil.

Athanase Innovation AB  (FRA:H6H) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Athanase Innovation AB Research & Development Related Terms

Athanase Innovation AB Research & Development Historical Data

* Premium members only.

The historical data trend for Athanase Innovation AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB Research & Development Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
Research & Development
0.00 0.00 0.00

Athanase Innovation AB Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
FRA:H6H
26GF Score
Athanase Innovation AB FRA:H6H
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athanase Innovation AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Athanase Innovation AB (FRA:H6H) has a Research & Development of €0.00 Mil as of Dec. 2020. Research and development expense is the total cost for research and development activities. View historical data on Athanase Innovation AB and its competitors.
Is Athanase Innovation AB's Research & Development too high?
Athanase Innovation AB's current Research & Development is €0.00 Mil. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's Research & Development compare to ?
Athanase Innovation AB's Research & Development of €0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Athanase Innovation AB and its competitors. Athanase Innovation AB's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (FRA:H6H) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Athanase Innovation AB (FRA:H6H), the current Research & Development is €0.00 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Athanase Innovation AB Business Description

Comparable Companies
Address Birger Jarlsgatan 6, Sverige, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score

Get the complete analysis for FRA:H6H

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.77
Price